Related Experiment Video
Updated: Aug 23, 2026
Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material
Published on: August 1, 2018
BC200 RNA in invasive and preinvasive breast cancer
Anna Iacoangeli1, Yuan Lin, Eric J Morley
1Department of Physiology and Pharmacology, State University of New York, Health Science Center at Brooklyn, Brooklyn, NY 11203, USA.
Abstract:
BC200 RNA, a small functional RNA that operates as a translational modulator, has been implicated in the regulation of local synaptodendritic protein synthesis in neurons. Cell type-specific expression of BC200 RNA is tightly controlled such that the RNA is not normally detected in somatic cells other than neurons. However, the neuron-specific control of BC200 expression is deregulated in a number of tumors. We here report that BC200 RNA is expressed at high levels in invasive carcinomas of the breast. In normal breast tissue or in benign tumors such as fibroadenomas, in contrast, we found that the RNA is not detectable at significant levels. The difference in expression levels between invasive carcinomas and normal/benign tissue was statistically highly significant. Receiver Operating Characteristics analysis of sensitivity and specificity confirmed the diagnostic power of BC200 RNA as a molecular marker of invasive breast cancer. In ductal carcinomas in situ, furthermore, significant BC200 expression was associated with high nuclear grade, suggesting that the presence of BC200 RNA in such tumors may be used as a prognostic indicator of tumor progression. The combined results demonstrate the potential of BC200 expression to serve as a molecular tool in the diagnosis and/or prognosis of breast cancer.
Insights
BC200 RNA, a key regulator of protein synthesis, is highly expressed in invasive breast cancer but not in normal or benign breast tissue. This finding highlights BC200 RNA
Area of Science:
- Molecular Biology
- Oncology
- RNA Biology
Background:
- BC200 RNA is a small functional RNA involved in regulating protein synthesis in neurons.
- Its expression is normally restricted to neurons, but deregulation is observed in some tumors.
- Aberrant BC200 RNA expression is linked to various cancers.
Purpose of the Study:
- To investigate BC200 RNA expression levels in breast cancer tissues.
- To evaluate BC200 RNA as a potential diagnostic and prognostic marker for breast cancer.
Main Methods:
- Quantitative analysis of BC200 RNA expression in invasive breast carcinomas, normal breast tissue, benign tumors (fibroadenomas), and ductal carcinomas in situ.
- Statistical analysis, including Receiver Operating Characteristics (ROC) analysis, to assess diagnostic accuracy.
- Correlation analysis between BC200 RNA levels and tumor grade in ductal carcinomas in situ.
Main Results:
- BC200 RNA was found at significantly higher levels in invasive breast carcinomas compared to normal or benign breast tissues.
- BC200 RNA expression demonstrated high sensitivity and specificity as a marker for invasive breast cancer.
- In ductal carcinomas in situ, elevated BC200 RNA expression correlated with higher nuclear grade.
Conclusions:
- BC200 RNA is a promising molecular marker for the diagnosis of invasive breast cancer.
- BC200 RNA expression may serve as a prognostic indicator for tumor progression, particularly in ductal carcinomas in situ.
- Further research into BC200 RNA's role could lead to improved breast cancer detection and management strategies.
